Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Watson · SciRah

Researcher profile · Semantic Scholar

S. Watson

Share profile

S. Watson — researcher profile on SciRah

h-index: 11
Works: 27
Citations: 1,258

Most-cited papers

The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients.
B. Alman, S. Attia, C. Baumgarten, C. Benson +53 more
2020European Journal of Cancer463 citations Open access
Semantic Scholar
Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial
R. Fitzgerald, M. di Pietro, M. O'Donovan, R. Maroni +212 more
2020The Lancet191 citations Open access
Semantic Scholar
Pragmatic issues in biomarker evaluation for targeted therapies in cancer
A. de Gramont, S. Watson, L. Ellis, J. Rodón +3 more
2015Nature Reviews Clinical Oncology185 citations
Semantic Scholar
Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients.
P. Chaı̈bi, N. Magné, S. Breton, A. Chebib +7 more
2011Critical reviews in oncology/hematology182 citations
Semantic Scholar
Targeting the VEGF Pathway in Osteosarcoma
T. Assi, S. Watson, Bachar Samra, E. Rassy +3 more
2021Cells63 citations Open access
Semantic Scholar
Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study.
S. Watson, P. Validire, P. Cervera, N. Zorkani +8 more
2013Annals of Oncology48 citations Open access
Semantic Scholar
Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST).
S. Watson, C. de la Fouchardiére, Stefano Kim, R. Cohen +8 more
2019European Journal of Cancer26 citations
Semantic Scholar
Desmoid tumors: who, when and how to treat?
Rabih Mikhael, Myles J. Smith, D. Tzanis, S. Watson +2 more
2022Current Opinion in Oncology19 citations
Semantic Scholar
Single‐agent gemcitabine in patients with advanced, pre‐treated angiosarcoma: A multicenter, retrospective study
S. Watson, B. Verret, S. Ropert, J. Adam +16 more
2022Cancer Medicine19 citations Open access
Semantic Scholar
Significant Predictors of Postoperative Morbidity After Radical Resection of Retroperitoneal Sarcoma in a Tertiary Center
Claudia Di Prata, B. Renouf, D. Tzanis, T. Bouhadiba +7 more
2023Annals of Surgical Oncology17 citations
Semantic Scholar
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
S. Watson, J. Menis, C. Baldini, P. Martin-Romano +7 more
2018British Journal of Cancer14 citations Open access
Semantic Scholar
Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 Pembrolizumab
L. Djerroudi, J. Masliah-Planchon, H. Brisse, S. El Zein +7 more
2023JCO Precision Oncology9 citations Open access
Semantic Scholar
Letter: Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era.
O. Mir, S. Watson, J. Blay
2020Neurosurgery5 citations Open access
Semantic Scholar
Nivolumab activity in advanced refractory malignant peritoneal mesothelioma.
Ondine Becker, Clément Beaulaton, Julien Masliah-Planchon, V. Servois +1 more
2020European Journal of Cancer5 citations
Semantic Scholar
Evaluation of PFS ratio in patients with cancer enrolled in early-phase clinical trials: A single center, retrospective analysis.
S. Watson, C. Bonnet, J. Menis, J. Michot +5 more
20174 citations
Semantic Scholar
LEIOMYOSARCOMA AND LIPOSARCOMA IN YOUNG PATIENTS: THE NATIONAL NETSARC+ NETWORK EXPERIENCE
Anne-Laure Genevois, M. Carton, M. Jean-Denis, J. Cyrta +26 more
2023EJC Paediatric Oncology3 citations Open access
Semantic Scholar
Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus-Associated Gastric Adenocarcinoma With ERBB2 Amplification.
S. Watson, J. Cyrta, M. Lefevre, J. M. Planchon +6 more
2021JCO Precision Oncology3 citations
Semantic Scholar
Neoadjuvant Everolimus for Adult Giant Mesenteric Cystic Lymphangioma with mTOR Pathway Activation.
S. El Zein, N. Gruel, S. Bonvalot, O. Mir +1 more
2021The Oncologist2 citations Open access
Semantic Scholar
Erratum to 'Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)' [Eur J Cancer 107 (January 2019) 46-52].
S. Watson, C. de la Fouchardiére, Stefano Kim, R. Cohen +8 more
2019European Journal of Cancer1 citations Open access
Semantic Scholar
Comparison of HER2 expression in paired biopsies and surgical specimen of gastric and esophageal adenocarcinoma: Impact of neoadjuvant chemotherapy.
S. Watson, P. Validire, P. Cervera, N. Zorkani +5 more
20171 citations
Semantic Scholar
Comparison of HER-2 expression in diagnostic biopsies and surgical specimens of gastric and esophageal adenocarcinoma: Influence of neoadjuvant chemotherapy.
S. Watson, P. Validire, P. Cervera, N. Zorkani +8 more
20131 citations
Semantic Scholar
ASO Visual Abstract: Significant Predictors of Postoperative Morbidity After Radical Resection of Retroperitoneal Sarcoma in a Tertiary Center
Claudia Di Prata, B. Renouf, D. Tzanis, T. Bouhadiba +7 more
2023Annals of Surgical Oncology0 citations
Semantic Scholar
ASO Visual Abstract: Percutaneous Uterine Needle Biopsy with Microscopic and Array-CGH Analyses for Preoperative Sarcoma Diagnosis in Patients with Suspicious Myometrial Tumors on MRI: A Prospective Pilot Study (SARCGYN)
J. Smadja, S. El Zein, G. Pierron, S. Watson +5 more
2022Annals of Surgical Oncology0 citations
Semantic Scholar
Activity of single-agent gemcitabine in patients (pts) with advanced angiosarcoma: A retrospective study.
S. Watson, B. Verret, S. Ropert, J. Adam +16 more
20210 citations
Semantic Scholar
Oxaliplatin, 5FU and nab-paclitaxel as neoadjuvant regimen in patients with resectable oesogastric adenocarcinoma: A GERCOR phase 2 study (FOXAGAST).
S. Watson, C. de la Fouchardiére, Stefano Kim, R. Cohen +8 more
20180 citations
Semantic Scholar
HER2 et cancer œsogastrique : implications en pratique clinique
S. Watson, C. Louvet
20140 citations
Semantic Scholar
21 Weekly paclitaxel and three weekly docetaxel appear active and well-tolerated in third and fourth-line advanced NSCLC patients
A. Pender, I. Letsa, A. Reid, T. Waddell +10 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Bonvalot×7
Invite
S. Bonvalot — researcher profile on SciRah
C. Louvet×7
Invite
C. Louvet — researcher profile on SciRah
C. Tournigand×6
Invite
C. Tournigand — researcher profile on SciRah
S. El Zein×6
Invite
S. El Zein — researcher profile on SciRah

×5

Invite

O. Mir — researcher profile on SciRah

Invite

D. Tzanis — researcher profile on SciRah

Invite

A. Le Cesne — researcher profile on SciRah

Invite

M. Lefevre — researcher profile on SciRah

Invite

M. Svrcek — researcher profile on SciRah

Invite

J. Blay — researcher profile on SciRah

Invite

P. Cervera — researcher profile on SciRah

Invite

N. Zorkani — researcher profile on SciRah